StricklandS., and MahdaviV. (1978). The induction of differentiation in teratocarcinoma stem cells by retinoic acid.Cell15, 393–403.
2.
StricklandS. (1981). Mouse teratocarcinoma cells: prospects for the study of embryogenesis and neoplasia.Cell24, 277–278.
3.
SmithM.K., KimmelG.L., KochlarD.M., ShepardT.H., SpielbergS.P., and WilsonJ.G. (1983). A selection of candidate compounds for in vitro teratogenesis test validation.Teratogenesis, Carcinogenesis and Mutagenesis3, 461–480.
4.
ClothierR.H., HulmeL., AhmedA.H., ReevesH.L., SmithM., and BallsM. (1988). In vitro cytotoxicity of 150 chemicals to 3T3-L1 cells, assessed by the FRAME kenacid blue method.ATLA16, 84–95.
5.
KnoxP., UphillP.F., FryJ.R., BenfordJ., and BallsM. (1986). The FRAME multicentre project on in vitro cytotoxicology.Food and Chemical Toxicology24, 457–463.
6.
DalyA.K., and RedfernC.P.F. (1987). Characterisation of a retinoic-acid-binding component from F9 embryonal-carcinoma-cell nuclei.European Journal of Biochemistry168, 133–139.
7.
RiddellR.J., PanacerD.S., WildeS.M., ClothierR.H., and BallsM. (1986). The importance of exposure period and cell type in in vitro cytotoxicity tests.ATLA14, 86–92.
